Life Science REIT PLC (LABS) — Cash Flow Reinvestment Rate
Life Science REIT PLC (LABS) has a Cash Flow Reinvestment Rate of 6.06x as of June 2025, reinvesting GBX5.81 Million (capex GBX5.81 Million ) from operating cash flow of GBX958.00K. See LABS FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Life Science REIT PLC Cash Flow Reinvestment Rate (2021–2024)
Historical reinvestment intensity for Life Science REIT PLC across 3 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Life Science REIT PLC.
Annual Cash Flow Reinvestment Rate for Life Science REIT PLC (2021–2024)
Year-by-year capital reinvestment analysis for Life Science REIT PLC. See LABS financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (GBX) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.76x | GBX35.63 Million | GBX12.92 Million | GBX19.28 Million | ▼ -41.1% |
| 2023 | 4.69x | GBX35.68 Million | GBX7.62 Million | GBX24.03 Million | ▼ -91.2% |
| 2021 | 53.46x | GBX189.16 Million | GBX3.54 Million | GBX7.64 Million | — |